Buscar
Mostrando ítems 1-10 de 96
Cholinesterase inhibitors for Alzheimer's disease: Multitargeting strategy based on anti-Alzheimer's drugs repositioning
(Bentham Science Publishers, 2019)
Spectrofluorimetry in organized media coupled to second-order multivariate calibration for the determination of galantamine in the presence of uncalibrated interferences
(Elsevier Science, 2010-06)
The present article describes the spectrofluorimetric determination of galantamine, a widely used<br />acetylcholinesterase inhibitor, through excitation–emission fluorescence matrices and second-order calibration. With ...
High-performance liquid chromatography with fast-scanning fluorescence detection and multivariate curve resolution for the efficient determination of galantamine and its main metabolites in serum
(Elsevier Science, 2012-06)
Based on green analytical chemistry principles, an efficient approach was applied for the simultaneous determination of galantamine, a widely used cholinesterase inhibitor for the treatment of Alzheimer's disease, and its ...
Amaryllidaceae del Tolima: importancia para el tratamiento de la enfermedad de Alzheimer
(Ediciones Unibagu?, 2021)
Evaluación de la actividad inhibitoria del extracto de alcaloides de Ismene narcissiflora sobre acetilcolinesterasa y butirilcolinesterasa.
(Escuela Superior Politécnica de Chimborazo, 2019-12-04)
The main objective of this research work was to determine the inhibitory activity of the alkaloid extract of Ismene narcissiflora, on the enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The Amaryllidaceae ...
Determinación de actividad inhibitoria de acetilcolinesterasa y butirilcolinesterasa del extracto de alcaloides de Phaedranassa cinérea.
(Escuela Superior Politécnica de Chimborazo, 2017-11)
The objective of the study was to fine-tune the method of Ellman et al., Described by López in 2002 for the determination of acetylcholinesterase inhibitory activity (AChE) and butyrylcholinesterase (BuChE) and to quantify ...
Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia
Background: Schizophrenia is a severe, persistent mental disorder, and a leading cause of disability worldwide. Cognitive impairments presented in schizophrenia lead to a worse prognostic, thus treatments targeted to enhance ...